Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide ll37

Biophysical Journal

Volumn 98, Issue 2, 2010, Pages 248-257

  Thennarasu, Sathiah ^a   Tan, Anmin ^a   Penumatchu, Rajesh ^b   Shelburne, Charles E ^a   Heyl, Deborah L ^b   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; POSIBACTERIA;

EID: 77049098530     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.09.060     Document Type: Article

References (34)

1. Zanetti, M., R. Gennaro,., R. Circo. 2002. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 8:779-793.
2. Scott, M. G., D. J. Davidson,., R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883-3891.
3. Dürr, U. H. N., U. S. Sudheendra, and A. Ramamoorthy. 2006. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta. 1758:1408-1425.
4. Nijnik, A., and R. E. W. Hancock. 2009. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol. 16:41-47.
5. Mookherjee, N., and R. E. W. Hancock. 2007. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 64:922-933.
6. Rosenfeld, Y., N. Papo, and Y. Shai. 2005. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281: 1636-1643.
7. Oren, Z., J. C. Lerman,., Y. Shai. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341:501-513.
8. Ramamoorthy, A., D. K. Lee,., K. A. Henzler-Wildman. 2008. Nitrogen-14 solid-state NMR spectroscopy of aligned phospholipid bilayers to probe peptide-lipid interaction and oligomerization of membrane associated peptides. J. Am. Chem. Soc. 130:11023-11029.
9. Moon, J. Y., K. A. Henzler-Wildman, and A. Ramamoorthy. 2006. Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim. Biophys. Acta. 1758:1351-1358.
10. Li, Y., X. Li, H. Li, O. Lockridge, and Wang, G. A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation. Protein Expr. Purif. 54:157-165.
11. Porcelli, F., R. Verardi,., G. Veglia. 2008. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry. 47:5565-5572.
12. Wang, G. 2008. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 283:32637-32643.
13. Henzler Wildman, K. A., D. K. Lee, and A. Ramamoorthy. 2003. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry. 42:6545-6558.
14. Henzler-Wildman, K. A., G. V. Martinez,., A. Ramamoorthy. 2004. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry. 43:8459-8469.
15. Neville, F., M. Cahuzac,., D. Gidalevitz. 2004. The interaction of antimicrobial peptide LL-37 with artificial biomembranes: epifluorescence and impedance spectroscopy approach. J. Phys. Condens. Matter. 16:S2413-S2420.
16. Neville, F., M. Cahuzac,., D. Gidalevitz. 2006. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys. J. 90:1275-1287.
17. Sevcsik, E., G. Pabst,., K. Lohner. 2008. Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix. Biophys. J. 94:4688-4699.
18. Sood, R., and P. K. Kinnunen. 2008. Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L. Biochim. Biophys. Acta. 1778:1460-1466.
19. Sood, R., Y. Domanov,., P. K. Kinnunen. 2008. Binding of LL-37 to model biomembranes: insight into target vs host cell recognition. Biochim. Biophys. Acta. 1778:983-996.
20. Li, X., Y. Li,., G. Wang. 2006. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membranetargeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128:5776-5785.
21. Ramamoorthy, A., S. Thennarasu,., A. M. Krensky. 2006. Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta. 1758:154-163.
22. Hallock, K. J., K. A. Henzler Wildman,., A. Ramamoorthy. 2002. An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. Biophys. J. 82:2499-2503.
23. Ramamoorthy, A. 2009. Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights. Solid State Nucl. Magn. Reson. 35:201-207.
24. Bechinger, B., M. Zasloff, and S. J. Opella. 1993. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 2:2077-2084.
25. Page, R. C., C. Li,., T. A. Cross. 2007. Lipid bilayers: an essential environment for the understanding of membrane proteins. Magn. Reson. Chem. 45(S1):S2-S11.
26. Ramamoorthy, A., S. Thennarasu,., L. Maloy. 2006. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys. J. 91:206-216.
27. Bechinger, B. 2005. Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR spectroscopy study. Biochim. Biophys. Acta. 1712:101-108.
28. Wu, C. H., A. Ramamoorthy, and S. J. Opella. 1994. High-resolution heteronuclear dipolar solid-state NMR spectroscopy. J. Magn. Reson. A. 109:270-272.
29. Ramamoorthy, A., Y. Wei, and D. K. Lee. 2004. PISEMA solid-state NMR spectroscopy. Ann. Rep. NMR Spectrosc. 52:1-52.
30. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
31. Ikai, A. J. 1980. Thermostability and aliphatic index of globular proteins. J Biochem. 88:1895-1898.
32. Porcelli, F., B. Buck,., G. Veglia. 2004. Structure and orientation of pardaxin determined by NMR experiments in model membranes. J. Biol. Chem. 279:45815-45823.
33. Hallock, K. J., D. K. Lee,., A. Ramamoorthy. 2002. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 83:1004-1013.
34. Epand, R. M., and R. F. Epand. 2009. Domains in bacterial membranes and the action of antimicrobial agents. Mol. Biosyst. 5:580-587.